{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:43:43Z","timestamp":1786999423789,"version":"build-2736575974"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0899823X22002902_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Extracorporeal membrane oxygenation (ECMO) has been widely used in the care of patients with respiratory failure from coronavirus disease 2019 (COVID-19). We characterized bloodstream infections (BSIs) and ventilator-associated pneumonias (VAPs) in COVID-19 patients supported with ECMO, and we investigated their impact on patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as2\">\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study from March 1, 2020, to June 30, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as3\">\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Academic tertiary-care referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as4\">\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Consecutive adult patients admitted for COVID-19 who received ECMO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as5\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified BSIs and VAPs and described their epidemiology and microbiology. Cumulative antimicrobial use and the specific management of BSIs were determined. Multivariate time-dependent Cox proportional hazards models were constructed to evaluate the impact of BSIs and VAPs on mortality, controlling for age, receipt of COVID-19\u2013specific therapeutics, and new renal replacement therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as6\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We identified 136 patients who received ECMO for COVID-19 pneumonia during the study period. BSIs and VAPs occurred in 81 patients (59.6%) and 93 patients (68.4%), respectively. The incidence of BSIs was 29.5 per 1,000 ECMO days and increased with duration of ECMO cannulation. Enterococci, Enterobacterales, and\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      were the most common causes of BSIs, whereas\n                      <jats:italic>S. aureus<\/jats:italic>\n                      ,\n                      <jats:italic>Klebsiella<\/jats:italic>\n                      species, and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      comprised the majority of VAPs. Mean antibiotic use comprised 1,031 days of therapy per 1,000 ECMO days (SD, 496). We did not detect an association between BSIs or VAPs and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X22002902_as7\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>BSIs and VAPs are common in COVID-19 ECMO-supported patients. Efforts to optimize their diagnosis, prevention, and management should be prioritized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ice.2022.290","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:03:25Z","timestamp":1669853005000},"page":"1443-1450","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":15,"title":["Bloodstream infection and ventilator-associated pneumonia in patients with coronavirus disease 2019 (COVID-19) supported by extracorporeal membrane oxygenation"],"prefix":"10.1017","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-4132","authenticated-orcid":false,"given":"Charlie","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-7033","authenticated-orcid":false,"given":"Susy S.","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-3610","authenticated-orcid":false,"given":"Krista","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Vicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"S0899823X22002902_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2011.09.013"},{"key":"S0899823X22002902_ref18","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.61"},{"key":"S0899823X22002902_ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002190"},{"key":"S0899823X22002902_ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800385"},{"key":"S0899823X22002902_ref19","unstructured":"19. Bloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection). Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/4psc_clabscurrent.pdf. Published 2021. Accessed November 15, 2022."},{"key":"S0899823X22002902_ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03013-2"},{"key":"S0899823X22002902_ref22","doi-asserted-by":"publisher","DOI":"10.1086\/668439"},{"key":"S0899823X22002902_ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068723"},{"key":"S0899823X22002902_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00096-5"},{"key":"S0899823X22002902_ref25","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2022.116"},{"key":"S0899823X22002902_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32008-0"},{"key":"S0899823X22002902_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.03.011"},{"key":"S0899823X22002902_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002652"},{"key":"S0899823X22002902_ref16","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2018.90"},{"key":"S0899823X22002902_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.70"},{"key":"S0899823X22002902_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.016"},{"key":"S0899823X22002902_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.04.024"},{"key":"S0899823X22002902_ref30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MAT.0000000000000771","article-title":"Cannula-related infection in patients supported by peripheral ECMO: clinical and microbiological characteristics","volume":"65","author":"Allou","year":"2019","journal-title":"ASAIO J"},{"key":"S0899823X22002902_ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03634-1"},{"key":"S0899823X22002902_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3181e28894"},{"key":"S0899823X22002902_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis783"},{"key":"S0899823X22002902_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2009.07.016"},{"key":"S0899823X22002902_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00090-2"},{"key":"S0899823X22002902_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61069-2"},{"key":"S0899823X22002902_ref8","unstructured":"8. Clinical management of COVID-19: living guidance. World Health Organization website. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Clinical-2022. Published September 15, 2022. Acessed November 15, 2022."},{"key":"S0899823X22002902_ref21","unstructured":"21. Pneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU]) event. Centers for Disease Control and Prevention website. https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/6pscVAPcurrent.pdf. Published 2021. Accessed November 15, 2022."},{"key":"S0899823X22002902_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30328-3"},{"key":"S0899823X22002902_ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0335-9"},{"key":"S0899823X22002902_ref31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MAT.0000000000001337","article-title":"Microbial colonization of oxygenator and clinical outcomes in extracorporeal membrane oxygenation","volume":"67","author":"Kim","year":"2021","journal-title":"ASAIO J"},{"key":"S0899823X22002902_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2019.01.004"},{"key":"S0899823X22002902_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.018"},{"key":"S0899823X22002902_ref13","doi-asserted-by":"publisher","DOI":"10.1086\/515200"},{"key":"S0899823X22002902_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001422"},{"key":"S0899823X22002902_ref34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab118"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X22002902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T03:37:09Z","timestamp":1711942629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X22002902\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0899823X22002902"],"URL":"https:\/\/doi.org\/10.1017\/ice.2022.290","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"\u00a9 The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}